Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Dewi Shri Farmindo Tbk. (DEWI) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Dewi Shri Farmindo Tbk.Trade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Dewi Shri Farmindo Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Dewi Shri Farmindo Tbk. trades at Rp121 (market cap 238B, 102.65M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp146 (market cap 584.6B, 817.3K 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 2.5× Dewi Shri Farmindo Tbk.'s market cap, and Dewi Shri Farmindo Tbk. is more actively traded (102.65M versus 817.3K). Which is the better fit depends on your goals.

DEWILABS
Market Cap
238B584.6B
Volume
102.65M817.3K
Lot
1.03M8.17K
Turnover
12.2B120.01M
Average Price
118.83146.84
Value
12.2B120.01M
Indicative Equilibrium Price
121146
Indicative Equilibrium Volume
5.26K59

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DEWI
View details
LABS
View details

About Dewi Shri Farmindo Tbk.

PT Dewi Shri Farmindo Tbk (The "Company") is domiciled in Cianjur was established based on notarial deed No. 15 dated September 17, 2019 of Amaliyah, S.H.,M.Kn notary in Jakarta. The Company commenced commercial operations in 2019.

Read more on DEWI

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS